Kyung Min Lee Selected Research

Kyung Min Lee Research Topics

Disease

3	Liver Diseases (Liver Disease) 01/2022 - 01/2020
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2021 - 04/2009
3	Infections 01/2019 - 01/2014
2	Type 2 Diabetes Mellitus (MODY) 06/2022 - 01/2021
2	Non-alcoholic Fatty Liver Disease 01/2022 - 01/2020
2	COVID-19 01/2022 - 06/2021
2	Neoplasms (Cancer) 07/2021 - 10/2011
2	Carcinoma (Carcinomatosis) 01/2021 - 04/2020
2	Pulmonary Hypertension 01/2020 - 01/2018
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 01/2022
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022
1	Coronary Disease (Coronary Heart Disease) 10/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2021
1	Genetic Risk Score 10/2021
1	Ischemic Stroke 10/2021
1	Frailty 07/2021
1	Viremia 01/2021
1	Heart Failure 01/2021
1	Hemorrhage 01/2021
1	Hyponatremia 01/2021
1	Inflammation (Inflammations) 01/2021
1	Viral Hemorrhagic Septicemia 01/2021
1	Acute Kidney Injury (Acute Renal Failure) 01/2021
1	Thrombosis (Thrombus) 01/2019
1	Pain (Aches) 01/2018
1	Premature Ejaculation 06/2017
1	Aneurysm (Aneurysms) 01/2016
1	Rupture 01/2016
1	Enophthalmos 09/2014
1	Candidiasis (Moniliasis) 01/2014
1	Lymphoma (Lymphomas) 10/2013
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 10/2013
1	Hypoxia (Hypoxemia) 01/2013
1	Disease Progression 01/2013
1	Bradycardia 10/2009
1	Myocardial Infarction 10/2009
1	Coronary Vasospasm (Coronary Artery Vasospasm) 10/2009
1	Hypotension (Low Blood Pressure) 10/2009
1	Heart Arrest (Cardiac Arrest) 10/2009
1	Subdural Hematoma (Subdural Hemorrhage) 04/2009
1	Drug-Related Side Effects and Adverse Reactions 04/2009

Drug/Important Bio-Agent (IBA)

3	ErbB Receptors (EGF Receptor)IBA 01/2021 - 04/2009
2	LipidsIBA 06/2022 - 01/2014
2	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 01/2020 - 01/2018
2	Vasodilator Agents (Vasodilators)IBA 01/2020 - 01/2018
1	Testosterone (Sustanon)FDA Link 01/2022
1	oxidized low density lipoproteinIBA 01/2022
1	O(4)-methylthymidine triphosphateIBA 01/2022
1	Alanine Transaminase (SGPT)IBA 01/2022
1	AndrogensIBA 01/2022
1	LDL CholesterolIBA 01/2022
1	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2022
1	Androgen Receptors (Androgen Receptor)IBA 01/2022
1	CholesterolIBA 01/2022
1	EnzymesIBA 10/2021
1	Pharmaceutical PreparationsIBA 06/2021
1	Azathioprine (Imuran)FDA LinkGeneric 06/2021
1	Vitamin A (Retinol)FDA LinkGeneric 06/2021
1	erucylphosphocholineIBA 01/2021
1	C-Reactive ProteinIBA 01/2021
1	Glycoproteins (Glycoprotein)IBA 01/2021
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2021
1	Vasopressins (Vasopressin)IBA 01/2021
1	GTP-Binding Proteins (G-Protein)IBA 01/2021
1	Platelet Membrane Glycoprotein IIbIBA 01/2021
1	moesinIBA 04/2020
1	ProteomeIBA 04/2020
1	Transaminases (Aminotransferases)IBA 01/2020
1	GoldIBA 01/2020
1	Alanine (L-Alanine)FDA Link 01/2020
1	Mitochondrial DNA (mtDNA)IBA 01/2019
1	Factor Xa (Coagulation Factor Xa)IBA 01/2019
1	dapoxetineIBA 06/2017
1	TitaniumIBA 09/2014
1	HydrogelsIBA 01/2014
1	adenovirus receptorIBA 01/2014
1	Voriconazole (Vfend)FDA LinkGeneric 01/2014
1	MicroRNAs (MicroRNA)IBA 10/2011
1	Prostaglandins EIBA 10/2009
1	ProstaglandinsIBA 10/2009
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 04/2009
1	Gefitinib (Iressa)FDA Link 04/2009

Therapy/Procedure

5	Therapeutics 01/2022 - 04/2009
2	Radiotherapy 07/2021 - 01/2018
2	Aftercare (After-Treatment) 09/2014 - 10/2013
1	Drug Therapy (Chemotherapy) 07/2021
1	Glycemic Control 01/2021
1	Artificial Respiration (Mechanical Ventilation) 01/2021
1	Percutaneous Coronary Intervention 01/2021
1	Vascular Closure Devices 01/2021
1	Stents 01/2016
1	Stem Cell Transplantation 10/2013
1	Noninvasive Ventilation 01/2013